Clinical management of uterine papillary serous carcinoma

被引:15
作者
Roelofsen, Thijs [1 ]
van Ham, Maaike A. [1 ]
de Hullu, Joanne A. [1 ]
Massuger, Leon F. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol 791, NL-6500 HB Nijmegen, Netherlands
关键词
comprehensive surgical staging; cytoreductive surgery; endometrial cancer; papillary serous carcinoma; radiation therapy; uterine chemotherapy; PLATINUM-BASED CHEMOTHERAPY; CLEAR-CELL CARCINOMA; WHOLE ABDOMINOPELVIC RADIATION; EPITHELIAL OVARIAN-CARCINOMA; GYNECOLOGIC-ONCOLOGY-GROUP; LONG-TERM SURVIVAL; STAGE-I PATIENTS; ENDOMETRIAL CANCER; NEOADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY;
D O I
10.1586/ERA.10.199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uterine papillary serous carcinoma (UPSC) is an aggressive variant of endometrial cancer. Owing to its rarity, most clinicians are unfamiliar with the clinical aspects and management of UPSC. Furthermore, little prospective evidence exists regarding how best to treat this subset of patients. In anticipation of prospective clinical trials, this article summarizes the latest results of various clinical management options in the different substages of UPSC, with a special focus on the effects of cytoreductive surgery, comprehensive surgical staging and different adjuvant treatment options in relation to recurrence rate and survival outcome.
引用
收藏
页码:71 / 81
页数:11
相关论文
共 94 条
[1]   Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer [J].
Alektiar, Kaled M. ;
Makker, Vicky ;
Abu-Rustum, Nadeem R. ;
Soslow, Robert A. ;
Chi, Dennis S. ;
Barakat, Richard R. ;
Aghajanian, Carol A. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :142-145
[2]   Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer [J].
Amant, F ;
Cadron, I ;
Fuso, L ;
Berteloot, P ;
de Jonge, E ;
Jacomen, G ;
Van Robaeys, J ;
Neven, P ;
Moerman, P ;
Vergote, I .
GYNECOLOGIC ONCOLOGY, 2005, 98 (02) :274-280
[3]   Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma [J].
Bancher-Todesca, D ;
Neunteufel, W ;
Williams, KE ;
Prainsack, D ;
Breitenecker, G ;
Friedlander, ML ;
Hacker, NF .
GYNECOLOGIC ONCOLOGY, 1998, 71 (03) :344-347
[4]   2 PATHOGENETIC TYPES OF ENDOMETRIAL CARCINOMA [J].
BOKHMAN, JV .
GYNECOLOGIC ONCOLOGY, 1983, 15 (01) :10-17
[5]   The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma [J].
Bristow, RE ;
Duska, LR ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2001, 81 (01) :92-99
[6]   Extended surgical staging for uterine papillary serous carcinoma: Survival outcome of locoregional (Stage I-III) disease [J].
Bristow, RE ;
Asrari, F ;
Trimble, EL ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2001, 81 (02) :279-286
[7]   UTERINE PAPILLARY SEROUS CARCINOMA - A STUDY ON 108 CASES WITH EMPHASIS ON THE PROGNOSTIC-SIGNIFICANCE OF ASSOCIATED ENDOMETRIOID CARCINOMA, ABSENCE OF INVASION, AND CONCOMITANT OVARIAN-CARCINOMA [J].
CARCANGIU, ML ;
CHAMBERS, JT .
GYNECOLOGIC ONCOLOGY, 1992, 47 (03) :298-305
[8]   Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide [J].
Chambers, JT ;
Chambers, SK ;
Kohorn, EI ;
Carcangiu, ML ;
Schwartz, PE .
GYNECOLOGIC ONCOLOGY, 1996, 60 (03) :438-442
[9]   Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium [J].
Chan, JK ;
Loizzi, V ;
Youssef, M ;
Osann, K ;
Rutgers, J ;
Vasilev, SA ;
Berman, ML .
GYNECOLOGIC ONCOLOGY, 2003, 90 (01) :181-185
[10]   Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma [J].
Cirisano, FD ;
Robboy, SJ ;
Dodge, RK ;
Bentley, RC ;
Krigman, HR ;
Synan, IS ;
Soper, JT ;
Clarke-Pearson, DL .
GYNECOLOGIC ONCOLOGY, 1999, 74 (03) :385-394